DE602004002473D1 - Herstellung von quinapril hydrochlorid - Google Patents

Herstellung von quinapril hydrochlorid

Info

Publication number
DE602004002473D1
DE602004002473D1 DE602004002473T DE602004002473T DE602004002473D1 DE 602004002473 D1 DE602004002473 D1 DE 602004002473D1 DE 602004002473 T DE602004002473 T DE 602004002473T DE 602004002473 T DE602004002473 T DE 602004002473T DE 602004002473 D1 DE602004002473 D1 DE 602004002473D1
Authority
DE
Germany
Prior art keywords
preparation
quinapril hydrochloride
quinapril
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004002473T
Other languages
English (en)
Other versions
DE602004002473T2 (de
Inventor
Sandra Marie Jennings
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE602004002473D1 publication Critical patent/DE602004002473D1/de
Application granted granted Critical
Publication of DE602004002473T2 publication Critical patent/DE602004002473T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DE602004002473T 2003-03-31 2004-03-19 Herstellung von quinapril hydrochlorid Expired - Fee Related DE602004002473T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45901603P 2003-03-31 2003-03-31
US459016P 2003-03-31
PCT/IB2004/000942 WO2004087671A1 (en) 2003-03-31 2004-03-19 Preparation of quinapril hydrochloride

Publications (2)

Publication Number Publication Date
DE602004002473D1 true DE602004002473D1 (de) 2006-11-02
DE602004002473T2 DE602004002473T2 (de) 2007-06-14

Family

ID=33131855

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004002473T Expired - Fee Related DE602004002473T2 (de) 2003-03-31 2004-03-19 Herstellung von quinapril hydrochlorid

Country Status (22)

Country Link
US (1) US6858735B2 (de)
EP (1) EP1611106B1 (de)
JP (1) JP2006522092A (de)
KR (1) KR20050115323A (de)
CN (1) CN1747935A (de)
AR (1) AR043949A1 (de)
AT (1) ATE340161T1 (de)
AU (1) AU2004226154B2 (de)
BR (1) BRPI0408924A (de)
CA (1) CA2517451C (de)
CL (1) CL2004000541A1 (de)
DE (1) DE602004002473T2 (de)
DK (1) DK1611106T3 (de)
ES (1) ES2271868T3 (de)
MX (1) MXPA05010498A (de)
PL (1) PL1611106T3 (de)
PT (1) PT1611106E (de)
RS (1) RS20050597A (de)
RU (1) RU2298004C2 (de)
TW (1) TWI284637B (de)
WO (1) WO2004087671A1 (de)
ZA (1) ZA200505214B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009053994A1 (en) * 2007-10-26 2009-04-30 Matrix Laboratories Limited Process for preparing pure amorphous quinapril hydrochloride
US10278742B2 (en) 2012-11-12 2019-05-07 DePuy Synthes Products, Inc. Interbody interference implant and instrumentation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4686295A (en) * 1982-03-10 1987-08-11 Usv Pharmaceutical Corporation N-carboxy anhydride intermediates
US4761479A (en) * 1987-03-30 1988-08-02 Warner-Lambert Company Crystalline quinapril and a process for producing the same
WO2002018321A2 (en) * 2000-08-29 2002-03-07 Abbott Laboratories Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
US6541635B1 (en) * 2002-03-29 2003-04-01 Everlight Usa, Inc. Method for producing angiotensin converting enzyme inhibitor
US7482361B2 (en) * 2002-12-16 2009-01-27 Lupin Limited Crystalline form for quinapril hydrochloride and process for preparing the same

Also Published As

Publication number Publication date
DK1611106T3 (da) 2006-12-27
EP1611106B1 (de) 2006-09-20
KR20050115323A (ko) 2005-12-07
CA2517451A1 (en) 2004-10-14
EP1611106A1 (de) 2006-01-04
ZA200505214B (en) 2008-08-27
US6858735B2 (en) 2005-02-22
RU2298004C2 (ru) 2007-04-27
BRPI0408924A (pt) 2006-04-04
CL2004000541A1 (es) 2005-02-04
ATE340161T1 (de) 2006-10-15
AU2004226154A1 (en) 2004-10-14
PL1611106T3 (pl) 2007-01-31
ES2271868T3 (es) 2007-04-16
RS20050597A (en) 2007-09-21
CA2517451C (en) 2009-04-21
JP2006522092A (ja) 2006-09-28
WO2004087671A1 (en) 2004-10-14
CN1747935A (zh) 2006-03-15
MXPA05010498A (es) 2005-11-16
US20040192613A1 (en) 2004-09-30
PT1611106E (pt) 2006-11-30
TW200424177A (en) 2004-11-16
DE602004002473T2 (de) 2007-06-14
AU2004226154B2 (en) 2007-03-08
AR043949A1 (es) 2005-08-17
TWI284637B (en) 2007-08-01
RU2005130402A (ru) 2006-02-10

Similar Documents

Publication Publication Date Title
DE602005018076D1 (de) Enantioselektive herstellung von chinolin-derivaten
ATE454138T1 (de) Tablette mit modifizierter freisetzung von bupropion hydrochlorid
DE60217126D1 (de) Herstellung von aminopyrimidinverbindungen
ATE461285T1 (de) Herstellung von tnfr-fc
DK1692242T3 (da) Viskoelastisk syre
DK1658263T3 (da) Aminobenzophenonforbindelser
DE60334857D1 (de) Kosmetische zubereitung
DK1587478T3 (da) Farmaceutisk sammensætning
DK1651044T3 (da) Flydende præparat
DE60304223D1 (de) Herstellung von metallamid-komplexen
DK1482936T3 (da) Öjenpræparat omfattende ascomycin
NO20043305D0 (no) Preparation of lodixanol
NO20060375L (no) Famasoytisk preparat
DE602004013599D1 (de) Herstellung von somatostatinpeptiden
DE602004003529D1 (de) Herstellung von Organohalosilanen
ATE546141T1 (de) Pharmazeutisches injektionspräparat
DE502004005544D1 (de) Mikrodosiereinrichtung
DE60333439D1 (de) Herstellung von olefinen
DE60307022D1 (de) Herstellung von Organohalosilanen
ITMI20031994A1 (it) Procedimento per la preparazione di fludarabina fosfato
DE602004002473D1 (de) Herstellung von quinapril hydrochlorid
ATE499348T1 (de) Stabiler polymorph von bifeprunoxmesilat
DK1685104T3 (da) Fremgangsmåde til fremstilling af N-substituerede phthalomider
ITMI20030018A1 (it) Procedimento per la preparazione di composti mono-
DE602004008992D1 (de) Herstellung von verzweigten Tetrasiloxanen

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: JENNINGS, SANDRA MARIE, ANN ARBOR, MI 48105, US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee